Qube Research & Technologies (QRT)’s Cogent Biosciences COGT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.2M	Buy	394,000 +117,272	+42%	+$4.33M	0.02%	1035
2025 Q4	$9.83M	Buy	276,728 +163,070	+143%	+$4.58M	0.01%	1355
2025 Q3	$1.63M	Buy	113,658 +94,756	+501%	+$1.12M	﹤0.01%	2326
2025 Q2	$136K	Buy	+18,902	New	+$105K	﹤0.01%	2984
2024 Q2	–	Sell	-123,017	Closed	-$827K	–	3923
2024 Q1	$827K	Buy	123,017 +5,849	+5%	+$36.2K	﹤0.01%	2255
2023 Q4	$689K	Buy	+117,168	New	+$898K	﹤0.01%	2119
2021 Q4	–	Sell	-38,213	Closed	-$321K	–	2582
2021 Q3	$321K	Sell	38,213 -17,374	-31%	-$133K	﹤0.01%	1458
2021 Q2	$451K	Buy	55,587 +6,546	+13%	+$55.3K	0.01%	1338
2021 Q1	$431K	Buy	+49,041	New	+$472K	0.01%	1266

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Qube Research & Technologies (QRT)'s COGT Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Cogent Biosciences (COGT) stake by 42% in Q1 2026, buying an estimated $4.33M and bringing the position to 394,000 shares worth $15.2M. The position accounts for 0.02% of the portfolio, ranked #1035.

Qube Research & Technologies (QRT) first reported a position in COGT in Q1 2021 and has held it in 9 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

Qube Research & Technologies (QRT) held 394,000 shares of Cogent Biosciences worth $15.2M as of Q1 2026.
Qube Research & Technologies (QRT) bought 117,272 Cogent Biosciences shares in Q1 2026, an estimated $4.33M.
Cogent Biosciences made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1035 holding.
Qube Research & Technologies (QRT) first reported a position in Cogent Biosciences in Q1 2021 and has held it in 9 quarters since.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.